Drug intelligence / Profile preview

forsythiaside

Development stage
Unknown
Lead developer
Guangdong Lewwin Pharmaceutical Research Institute
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Forsythiaside (specifically Forsythiaside A) is a phenylethanoid glycoside primarily isolated from the fruit of *Forsythia suspensa*, a traditional Chinese medicinal herb. Developed as a pharmaceutical candidate by Guangdong Lane Pharmaceutical Research Institute, it is being investigated for its potent broad-spectrum antiviral and anti-inflammatory properties in treating respiratory viral infections such as the common cold and influenza. The compound exhibits a dual mechanism of action: it inhibits viral replication by targeting neuraminidase activity and mitigates the inflammatory response by suppressing the NF-κB signaling pathway. This suppression leads to a significant reduction in the production of pro-inflammatory cytokines, including TNF-α and IL-6, which helps prevent the severe lung injury often associated with viral infections.

Other names
forsythiaside A(E)-forsythiasidelianqiaozhigan A
02

Targets

Peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha complexNFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on forsythiaside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on forsythiaside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call